Islam Saqib 4
4 · SpringWorks Therapeutics, Inc. · Filed Mar 5, 2025
Insider Transaction Report
Form 4
Islam Saqib
DirectorChief Executive Officer
Transactions
- Tax Payment
Common Stock
2025-02-27$53.41/sh−30,756$1,642,678→ 1,003,869 total - Sale
Common Stock
2025-03-03$52.97/sh−11,800$625,017→ 992,069 total - Sale
Common Stock
2025-03-03$54.24/sh−23,600$1,280,135→ 968,469 total - Sale
Common Stock
2025-03-03$55.15/sh−11,600$639,783→ 956,869 total - Sale
Common Stock
2025-03-03$56.13/sh−1,400$78,588→ 955,469 total - Sale
Common Stock
2025-03-03$56.89/sh−600$34,134→ 954,869 total
Footnotes (5)
- [F1]The sales reported on this Form 4 were effected pursuant to a trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, adopted on February 29, 2024.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.70 to $53.64. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.70 to $54.685. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F4]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.70 to $55.68. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F5]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.84 to $56.36. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.